tiprankstipranks
Trending News
More News >
MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235)
:2235
Hong Kong Market
Advertisement

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Financial Statements

Compare
0 Followers

MicroTech Medical (Hangzhou) Co., Ltd. Class H Financial Overview

MicroTech Medical (Hangzhou) Co., Ltd. Class H's market cap is currently HK$2.76B. The company's EPS TTM is HK$-0.06563402460000001; its P/E ratio is ―; MicroTech Medical (Hangzhou) Co., Ltd. Class H is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 345.62M¥ 248.35M¥ 173.54M¥ 151.40M¥ 75.28M
Gross Profit¥ 182.85M¥ 123.22M¥ 79.66M¥ 70.88M¥ 36.54M
Operating Income¥ -62.46M¥ -120.27M¥ -32.19M¥ -48.12M¥ -126.75M
EBITDA¥ -121.38M-¥ -21.71M¥ -39.80M¥ -121.27M
Net Income¥ -63.12M-¥ -37.74M¥ -48.18M¥ -115.51M
Balance Sheet
Cash & Short-Term Investments¥ 1.71B¥ 1.89B¥ 2.05B¥ 2.15B¥ 654.99M
Total Assets¥ 2.15B¥ 2.16B¥ 2.29B¥ 2.33B¥ 777.27M
Total Debt¥ 4.20M¥ 5.06M¥ 717.00K¥ 255.00K¥ 126.00K
Net Debt¥ -1.69B¥ -1.88B¥ -2.05B¥ -2.15B¥ -549.67M
Total Liabilities¥ 171.72M¥ 97.70M¥ 82.06M¥ 82.48M¥ 48.76M
Stockholders' Equity¥ 1.97B¥ 2.06B¥ 2.21B¥ 2.25B¥ 728.52M
Cash Flow
Free Cash Flow¥ -203.88M-¥ -137.45M¥ -62.94M¥ -35.26M
Operating Cash Flow¥ -120.65M-¥ -107.67M¥ -44.22M¥ -9.57M
Investing Cash Flow¥ 121.16M-¥ -965.58M¥ 97.69M¥ -1.22M
Financing Cash Flow¥ -33.15M¥ -23.46M¥ -20.57M¥ 1.57B¥ 511.28M
Currency in CNY

MicroTech Medical (Hangzhou) Co., Ltd. Class H Earnings and Revenue History

MicroTech Medical (Hangzhou) Co., Ltd. Class H Debt to Assets

MicroTech Medical (Hangzhou) Co., Ltd. Class H Cash Flow

MicroTech Medical (Hangzhou) Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis